全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Marine Drugs  2013 

Separacenes A–D, Novel Polyene Polyols from the Marine Actinomycete, Streptomyces sp.

DOI: 10.3390/md11082882

Keywords: marine actinomycete, polyene polyol, cytotoxicity, isocitrate lyase

Full-Text   Cite this paper   Add to My Lib

Abstract:

Separacenes A–D ( 1– 4), novel polyene polyols, were isolated from Streptomyces sp. collected from the southern area of Jeju Island, Korea. The chemical structures of 1– 4 were established by NMR, mass, UV, and IR spectroscopy as well as the modified Mosher’s method. Separacenes A–B ( 1– 2), which share an identical planar structure but possess different relative configurations, bear tetraene units flanked by two diol moieties, whereas the stereoisomeric separacenes C–D ( 3– 4) possess a triene moiety between two diol substructures. Separacenes A–D each contain a terminal olefinic methylene. Separacene A displayed inhibitory activity against Candida albicans isocitrate lyase and weak cytotoxicity against both the colon carcinoma cell line HCT-116 and the lung cancer cell line A549.

References

[1]  Li, J.W.-H.; Vederas, J.C. Drug discovery and natural products: End of an era or an endless frontier. Science 2009, 325, 161–165.
[2]  Weissman, K.J.; Leadlay, P.F. Combinatorial biosynthesis of reduced polyketides. Nat. Rev. Microbiol. 2005, 3, 925–936, doi:10.1038/nrmicro1287.
[3]  Clardy, J.; Walsh, C. Lessons from natural molecules. Nature 2004, 432, 829–837.
[4]  Bérdy, J. Bioactive microbial metabolites. J. Antibiot. 2005, 58, 1–26.
[5]  Fenical, W.; Jensen, P.R. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2, 666–673, doi:10.1038/nchembio841.
[6]  Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Drug. Discov. 2009, 8, 69–85, doi:10.1038/nrd2487.
[7]  Fenical, W.; Jensen, P.R.; Palladino, M.A.; Lam, K.S.; Lloyd, G.K.; Potts, B.C. Discovery and development of the anticancer agent salinosporamide A(NPI-0052). Bioorg. Med. Chem. 2009, 17, 2175–2180, doi:10.1016/j.bmc.2008.10.075.
[8]  Singh, R.; Sharma, M.; Joshi, P.; Rawat, D.S. Clinical status of anti-cancer agents derived from marine sources. Anti-Cancer Agents Med. Chem. 2008, 8, 603–617.
[9]  Kim, D.-G.; Moon, K.; Kim, S.-H.; Park, S.-H.; Park, S.; Lee, S.K.; Oh, K.-B.; Shin, J.; Oh, D.-C. Bahamaolides A and B, antifungal polyene polyol macrolides from the marine actinomycete, Streptomyces sp. J. Nat. Prod. 2012, 75, 959–967, doi:10.1021/np3001915.
[10]  Um, S.; Kim, Y.-J.; Kwon, H.; Wen, H.; Kim, S.-H.; Kwon, H.C.; Park, S.; Shin, J.; Oh, D.-C. Sungsanpin, a lasso peptide from a deep-sea streptomycete. J. Nat. Prod. 2013, 76, 873–879.
[11]  Félix, F.; Seco, J.M.; Qui?oá, E.; Riguera, R. Determining the absolute stereochemistry of secondary/secondary diols by 1H NMR: Basis and applications. J. Org. Chem. 2005, 70, 3778–3790, doi:10.1021/jo048643a.
[12]  Jiang, Z.D. Isolation of Antifungal Agents from Pine Roots. WO 9800091 A2, 8 January 1998.
[13]  Dunn, M.F.; Ramirez-Trujillo, J.A.; Hernandez-Lucas, I. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology 2009, 155, 3166–3175, doi:10.1099/mic.0.030858-0.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133